Shield Therapeutics shareholders told to reject £46.1m takeover offer One of the firm's long term shareholders has tabled an offer Birmingham Post · May 5, 2023
Shield Therapeutics hails US market progress and mulls stateside listing The Gateshead company said additional losses were to be expected as it carries out a plan to target US iron deficiency treatment demand Birmingham Post · Apr 27, 2023
People on the move: key North East appointments and promotions Companies featuring this week include Secure Trust Commercial Finance, Reproflex3 and Shield Therapeutics Birmingham Post · Apr 7, 2023